BRIEF-Medfield Diagnostics names Stefan Blomsterberg new CEO
* STEFAN BLOMSTERBERG TAKES OVER AS CEO AS OF AUG 8, 2017 AFTER CARL EKVALL Source text for Eikon: Further company coverage: (Gdynia Newsroom)
March 9 Tg Therapeutics Inc
* TG Therapeutics announces pricing of $50 million public offering of common stock
* Pricing of an underwritten public offering of 5.13 million shares of its common stock at a price of $9.75 per share Source text for Eikon: Further company coverage: (Bangalore.email@example.com)
KINSHASA, May 29 Democratic Republic of Congo's health ministry has approved the use of a new Ebola vaccine to counter an outbreak of the hemorrhagic fever in its northeast that has killed four people, a spokesman said on Monday.